CSF1R and Parkinson disease: This study adds to the growing literature on timing of microglial response in neurodegenerative disease by showing correlations between microglial proliferation and motor and cognitive disease severity in PD even at an early stage and that this can be measured with a novel radioligand targeting CSF1R, which has advantages over previously used PET ligands to detect inflammation in PD.